Utah's Amedica eyes $35 million IPO

Devicemaker Amedica is planning to go public with its sights on a $35 million IPO, offering 3.2 million shares at around $10 to $12 a piece. The Salt Lake City-based spinal implant specialist would operate under the Nasdaq symbol "AMDA." Item

Suggested Articles

Flatiron has hired a new chief medical officer as it looks to push on under its new parent in the world of electronic health records and real-world data.

Saga Diagnostics has raised 40 million Swedish kronor, or about $4.1 million, to help develop its ultrasensitive cancer liquid biopsy tests.

Terumo will help Orchestra BioMed develop its sirolimus-eluting balloon in both coronary and peripheral cardiovascular interventions.